Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
37626
CAS Number:
141430-65-1
ABT-751
Purity:
≥ 98 % (HPLC)
Synonym(s):
N- [2-[(4-Hidroxifenil)amino]piridin-3-il]-4-metoxibencenosulfonamida
Documents
$158.94 /10 mg
Tamaño
Request Bulk Quote
Información del producto

ABT-751 is a potent sulfonamide compound recognized for its application in cancer research, particularly as an inhibitor of the microtubule dynamics. This compound has shown promise in preclinical studies targeting various cancer types, including solid tumors. Its unique structure, featuring a pyridine ring and a sulfonamide group, enhances its ability to interfere with cellular processes, making it a valuable tool for researchers exploring novel therapeutic strategies.

In addition to its role in cancer treatment, ABT-751 has potential applications in the development of targeted therapies due to its ability to selectively inhibit tumor growth while minimizing effects on normal cells. This selectivity is crucial for improving patient outcomes and reducing side effects associated with traditional chemotherapy. Researchers and industry professionals can leverage ABT-751 in drug discovery and development, particularly in studies focused on overcoming drug resistance in cancer therapies.

Número CAS
141430-65-1
Fórmula molecular
C18H17N3O4S
Peso molecular
371.41
Número MDL
MFCD00910291
Punto de fusión
162 °C (descenso)
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
141430-65-1
Fórmula molecular
C18H17N3O4S
Peso molecular
371.41
Número MDL
MFCD00910291
Punto de fusión
162 °C (descenso)
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

ABT-751 is widely utilized in research focused on:

  • Cancer Treatment: This compound is being explored for its potential as an anti-cancer agent, particularly in targeting specific types of tumors, offering hope for more effective therapies.
  • Pharmaceutical Development: Researchers are investigating its properties to develop new medications that can improve patient outcomes in oncology, making it a valuable asset in drug formulation.
  • Biochemical Studies: ABT-751 serves as a tool in studying cellular mechanisms and pathways involved in cancer progression, aiding scientists in understanding disease biology.
  • Combination Therapies: It is being evaluated in conjunction with other drugs to enhance therapeutic efficacy, potentially leading to more effective treatment regimens for patients.
  • Targeted Therapy Research: The compound is part of ongoing studies aimed at developing targeted therapies that minimize side effects while maximizing treatment effectiveness, addressing a critical need in cancer care.

Citas